AATF knockdown reduces cell proliferation and promotes cell apoptosis in LPS-induced sepsis

Y. Li, L. Feng, Y. Zhao, Y. Cong, WL. Tang

Article ID: 4488
Vol 35, Issue 6, 2021
DOI: https://doi.org/10.54517/jbrha4488
Received: 8 January 2022; Accepted: 8 January 2022; Available online: 8 January 2022; Issue release: 8 January 2022

Abstract

The authors investigated the function of the apoptotic antagonistic transcription factor (AATF) inlipopolysaccharide (LPS)-induced H9C2 cell apoptosis and proliferation. After transfecting H9C2 cellswith short hairpin RNA (shRNA), a shAATF-162 gene interference model was established. Cells weredivided into mock, shRNA, and shNC groups and were treated with LPS. The cell counting kit-8 (CCK-8) assay and annexin V PE/7-AAD staining were used to assess cell viability and apoptosis, respectively.The protein levels of p53 upregulated modulator of apoptosis (PUMA) and phorbol-12-myristate-13-ac-etate-induced protein 1 (NOXA) were determined using western blotting. Interleukin 6 and tumor ne-crosis factor α (TNF-α) secretion was determined using enzyme-linked immunosorbent assay (ELISA)and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Results of the CCK-8assay showed that AATF knockdown decreased proliferation and potentiated apoptosis in LPS-inducedH9C2 cells compared with that in the shRNA and mock groups. The western blotting results indicatedthat AATF knockdown increased PUMA and NOXA protein levels in LPS-induced H9C2 cells comparedto that in the shNC and mock groups. ELISA and RT-qPCR results showed that AATF knockdown sig-nificantly decreased the LPS-induced secretion of IL-6 and TNF-α in H9C2 cells compared to that in theshNC and mock groups. This study showed that AATF inhibition attenuated cell viability, potentiatedapoptosis, and decreased the LPS-induced secretion of IL-6 and TNF-α in H9C2 cells


Keywords

sepsis;AATF;LPS;cell viability;cell apoptosis


References

Supporting Agencies



Copyright (c) 2021 Y. Li, L. Feng, Y. Zhao, Y. Cong, WL. Tang




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).